Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

24.36
+0.09500.39%
Volume:1.77M
Turnover:43.18M
Market Cap:3.08B
PE:-13.35
High:24.64
Open:24.06
Low:23.80
Close:24.26
Loading ...
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities